Symptoms Change But Savings OTC Drugs Deliver For US Health Care Spending Continue Growing
Executive Summary
Substantially more consumers in 2022 report sleep issues, allergies and skin problems than in 2018 while using quit smoking aids has dropped, according to CHPA’s latest “Value of OTC Medicines” survey. Average annual household spending on OTCs is $645.
You may also be interested in...
COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018
Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.
Providing High Value, OTC Drugs Deserve Higher Profile In Health Care – CHPA
While Rx drug pricing is under attack by Congress, White House and consumer and public health advocacy groups, OTC drugs' value isn't gaining a higher profile. "Our health care system undervalues the contribution of our industry's products," says CHPA chief Scott Melville. Trade group conducts “Value of OTC Medicines" study for reasons including raising the profile of consumer health products in the US health care system.
CHPA Quantifies OTCs’ Overall Value To Promote Expanded Access
Information from the CHPA-commissioned study could help improve policymakers’ understanding of the costs of making OTCs less available as well as the benefits of more Rx-to-OTC switches.